CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.17), $0.28 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $65.6 million versus the consensus estimate of $62.63 million.

GUIDANCE:

CareDx sees FY2024 revenue of $260-274 million, versus the consensus of $260.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.